This is a Phase 1, FIH, single-center, randomized, placebo-controlled, dose-escalation study to evaluate the safety, tolerability, PK, and PD of mRNA-1944 in healthy adult subjects.
Cohorts of mRNA-1944 are planned to be investigated in a sequential dose escalation manner.